Explore MARIMED INC by MariMed Inc. analyst ratings and price targets (OTC:MRMD) on Benzinga. Stay updated on expert opinions and forecasts for MRMD stock.
The latest price target for MARIMED INC by MariMed Inc. (OTCQB:MRMD) was reported by Zuanic & Associates on November 6, 2023. The analyst firm set a price target for $0.00 expecting MRMD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for MARIMED INC by MariMed Inc. (OTCQB:MRMD) was provided by Zuanic & Associates, and MARIMED INC by MariMed Inc. initiated their overweight rating.
There is no last upgrade for MARIMED INC by MariMed Inc.
There is no last downgrade for MARIMED INC by MariMed Inc..
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MARIMED INC by MariMed Inc., and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MARIMED INC by MariMed Inc. was filed on November 6, 2023 so you should expect the next rating to be made available sometime around November 6, 2024.
While ratings are subjective and will change, the latest MARIMED INC by MariMed Inc. (MRMD) rating was a initiated with a price target of $0.00 to $0.00. The current price MARIMED INC by MariMed Inc. (MRMD) is trading at is $0.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.